Matches in Nanopublications for { ?s ?p "[Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP331499.RAcr41XsiTwKhQoHpMmAPcb0W7xOoGaZ1Lv27KyCHwCw8130_assertion description "[Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331499.RAcr41XsiTwKhQoHpMmAPcb0W7xOoGaZ1Lv27KyCHwCw8130_provenance.
- NP706025.RAWPsBA6ydXAKlp8snkOiVxYC7X2_Q3-6yUN-qTrHDWlY130_assertion description "[Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP706025.RAWPsBA6ydXAKlp8snkOiVxYC7X2_Q3-6yUN-qTrHDWlY130_provenance.
- assertion description "[Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1066845.RAxBt3U04Q-UN-Bdu0asNUV5nNJKD7UXFEiNEDKsO_-Ss130_assertion description "[Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1066845.RAxBt3U04Q-UN-Bdu0asNUV5nNJKD7UXFEiNEDKsO_-Ss130_provenance.